Cardiovascular disease – which kills one Australian every 12 minutes — is caused by a hardening of the arteries due to abnormal deposits of fat and cholesterol (known as plaque) in the inner lining of the artery; a process known as atherosclerosis. When plaque deposits rupture, this can cause heart attacks and stroke. But what if the plaque could be prevented from rupturing using microscopic nanoparticles? Continue reading
Personnel from The South Australian Health and Medical Research Institute (SAHMRI) and the Centre for Nanoscale BioPhotonics (CNBP) came together today, to officially launch and celebrate a research partnership between the two organisations in the area of nano biophotonics.
SAHMRI, partnering with CNBP by hosting the Centre’s cardiovascular theme ‘Inside Blood Vessels’, will help to translate CNBP research into tangible outcomes. Using new probes and sensors developed by the CNBP, SAHMRI researchers will look to develop effective approaches to explore and better understand the factors at play within blood vessels and vascular health.
During launch proceedings, SAHMRI Executive Director, Professor Steve Wesselingh, spoke of his excitement at being able to link his researchers with such cutting edge physics and chemistry. He was also pleased that links between the two organisations will soon be further enhanced with CNBP postgraduate chemist Malcolm Purdey joining the SAHMRI research team from next year.
Professor Mark Hutchinson (CNBP Director), Professor Andrew Abell (CNBP Chief Investigator), Professor Steve Wesselingh (SAHMRI Executive Director) and Professor Stephen Nicholls (SAHMRI Deputy Director and CNBP Chief Investigator) all spoke during the launch proceedings, with the event culminating with the presentation to SAHMRI of a CNBP partner plaque.
CNBP looks forward to its ongoing collaborations with SAHMRI in this exciting area of research.
Pictured L to R below: Mark Hutchinson, Steve Wesselingh and Stephen Nicholls.
Ewa Goldys, CNBP Deputy Director undertook a special seminar for the Vascular Research Centre Group at the South Australian Health and Medical Research Institute (SAHMRI) during a visit on the 25th March, 2015.
Her talk titled, “Non-invasive imaging of biochemistry in cell populations,” looked at the development of specialised characterization hardware and analysis tools using hyperspectral imaging, which is able to identify cells within a population with differing biochemistry. She also discussed how this methodology responds to commercial and clinical needs across a broad spectrum of medicine and the life sciences.